YHR2501

DRUG2 trials

Sponsors

Yuhan Corporation

Conditions

Healthy SubjectHealthy Subjects

Phase 1

Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects

CompletedNCT06920719

Yuhan CorporationHealthy Subject

Start: 2025-06-29End: 2025-07-09Updated: 2025-07-24

Bioequivalence Study Between YHP2406 and YHR2501 in Healthy Subjects

CompletedNCT07265167

Yuhan CorporationHealthy Subjects

Start: 2025-10-18End: 2025-11-04Updated: 2025-12-04